Five Deals That Actually Moved the Needle This Week
Space wars. Doctors who don't sleep. AI lawyers billing at $1,200 an hour. Goldman writing healthcare checks. And Nvidia showing up in every cap table on earth. Five stories — one theme: the capital i
1. True Anomaly Just Raised $650M to Build Space Weapons for the Golden Dome
Series D: $650M
Valuation: $2.2B
Total raised: $1B
Founded: 2022
Colorado-based True Anomaly closed a $650 million Series D this week — co-led by Eclipse and Riot Ventures, with Paradigm, Atreides, and VanEck joining — pushing its total capital raised past $1 billion since its 2022 founding. The timing wasn't accidental: just four days before the announcement, the U.S. Space Force named True Anomaly one of 12 prime contractors on the Golden Dome space-based interceptor program, part of up to $3.2 billion in collective contracts. The company plans to double its headcount from 250 to 500 by year-end, expand manufacturing from 140,000 to 2 million square feet over four years, and fly a dozen missions in the next 18 months — including LEO, GEO, and cislunar operations with its Jackal autonomous orbital vehicle.
HOT TAKE
Four years old, $1 billion raised, zero commercial revenue — True Anomaly's entire business is the bet that space is a warfighting domain before it's a commercial one, and right now the U.S. government agrees.
MENTAL MODEL · THE CLEAN-SHEET ADVANTAGE
Every established defense prime — Lockheed, Raytheon, Northrop — carries decades of legacy requirements, cost-plus contracting habits, and internal politics that slow them down in a new domain. True Anomaly has none of that. They've built every system from scratch for space superiority, which means their architecture isn't constrained by what worked in 1995. The mental model here is the Clean-Sheet Advantage: when a new warfighting domain is being invented in real time, the company with no legacy to protect can outmaneuver incumbents not because it's smarter, but because it's not dragging an anchor. The question for investors and strategists isn't whether the Golden Dome program gets funded — it's whether True Anomaly's clean-sheet speed compounds faster than the primes' institutional weight.
2. Aidoc Raises $150M From Goldman — and Quietly Eyes an IPO
Series E: $150M
Total raised: $520M
Hospitals: ~2,000
Annual cases: 60M+
Aidoc closed a $150 million Series E on April 29 led by Goldman Sachs Growth Equity, with General Catalyst, SoftBank Vision Fund 2, and Nvidia's NVentures joining the round — bringing total funding to over $520 million. The company's CARE foundation model holds 31 FDA clearances, runs on nearly 2,000 hospital systems worldwide, and analyzes more than 60 million patient cases per year; diagnostic errors and delays cost roughly 400,000 American lives annually, the exact problem Aidoc is building against. CEO Elad Walach told Axios the company is eyeing an IPO within three to five years, and Goldman's growth equity team — which has deployed over $13 billion since 2003 — rarely writes a check without a public markets thesis in mind.
HOT TAKE
Goldman leading a healthcare AI round isn't a market signal — it's a market call. When the bank that prices IPOs starts backing the company, it's not early anymore.
3. Legora Just Got Nvidia Money — Making Its $600M Round the One to Watch in Legal Tech
Series D total: $600M
Valuation: $5.6B
Customers: 800+ firms
Markets: 50+
Swedish legal AI platform Legora extended its Series D to $600 million total this week after Nvidia's NVentures backed the company at a $5.6 billion valuation — Atlassian, Adams Street Partners, and Insight also joined the extension. The original $550 million Series D closed in March at $5.55 billion, tripling Legora's valuation in five months from its October 2025 Series C. The platform, built primarily on Anthropic's Claude, serves tens of thousands of lawyers at over 800 firms and in-house teams across 50+ markets including White & Case, Cleary Gottlieb, and Goodwin, with an average annual contract value of $280,000 per client.
HOT TAKE
Nvidia showing up in a legal AI cap table tells you exactly what this is: whoever wins the professional services AI stack will need serious compute, and Nvidia is buying optionality on all of them.
4. Rogo's $160M Series D Is Really a Bet That Wall Street's Junior Class Is Getting Automated
Series D: $160M
Total raised: $300M+
Users: 35,000+
Institutions: 250+
New York's Rogo closed a $160 million Series D led by Kleiner Perkins on April 29, with Sequoia, Thrive Capital, Khosla Ventures, and J.P. Morgan Growth Equity Partners all in the round — bringing total funding to over $300 million. More than 35,000 financial professionals at 250+ institutions, including Rothschild & Co, Jefferies, Lazard, and Nomura, use the platform daily; Rogo's newly launched agent Felix executes multi-step banking workflows autonomously from deal screening through data room diligence. The founders — Princeton classmates who left J.P. Morgan and Lazard jobs in 2022 after GPT-3 convinced them the timing was right — are now backed by the very institutions whose junior analyst pipelines they're restructuring.
HOT TAKE
J.P. Morgan Growth Equity writing a check into the startup automating J.P. Morgan's analyst work is either the most self-aware investment in finance history, or proof that they've already run the numbers on headcount.
5. Big Tech's Brain Drain Just Hit $18.8B — and the Checks Are Getting Bigger
2026 YTD AI lab funding: $18.8B
Ineffable seed: $1.1B
Ineffable valuation: $5.1B
Former DeepMind researcher David Silver — the man behind AlphaGo, AlphaZero, and MuZero — emerged from stealth this week with Ineffable Intelligence and a $1.1 billion seed round co-led by Sequoia and Lightspeed, with Nvidia, Google, DST Global, and the U.K. Sovereign AI Fund on the cap table, at a $5.1 billion valuation. He's the loudest example of a structural shift: according to CNBC, VCs have deployed $18.8 billion in 2026 alone into AI startups founded since January 2025, on pace to surpass the $27.9 billion raised by the prior year's founding cohort. The common thread is researchers leaving frontier labs — where narrow race dynamics have squeezed out whole research areas — to found companies where those bets can actually be made.
HOT TAKE
When the man who taught a machine to beat humans at Go calls his new company "his life's work" and pledges all personal equity proceeds to charity, $1.1 billion at the seed stage starts to feel like it's priced on something other than market comparables.